Session Title: Osteoarthritis – Clinical Aspect II: Treatment and Imaging
Session Type: ACR Concurrent Abstract Session
Session Time: 9:00AM-10:30AM
Results: Baseline characteristics were similar between groups. In both groups, significant increases in mean number and percent change of steps/day from baseline were observed; a significantly greater improvement in both outcomes was observed for Group A versus Group B (1199 vs 467, P=.0345 for number of steps/day; 35.81 vs 11.48, P=0.0189 for percent change of steps/day). In the 6-minute walk test, there was a greater improvement from baseline for Group A versus Group B in reducing pain (−55.3% vs −33.8%, P=0.0068) and increasing distance (18.2% vs 6.3%, P=0.9583). There was a greater number of patients (65.4%)/physicians (67.3%) who would be likely/very likely to use/recommend the devices than those who would be unlikely to do so. In both groups, PAM-13 scores improved from baseline however, no statistically significant differences were observed between groups (5.0% vs 6.9%, P=0.9931). The AE profiles were similar for the two arms.
To cite this abstract in AMA style:Skrepnik N, Spitzer A, Altman R, Hoekstra JA, Stewart J, Toselli R. Impact of Novel Smartphone Application on Pain and Mobility in Osteoarthritis Patients Treated with Hylan G-F 20 [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/impact-of-novel-smartphone-application-on-pain-and-mobility-in-osteoarthritis-patients-treated-with-hylan-g-f-20/. Accessed December 1, 2020.
« Back to 2016 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-novel-smartphone-application-on-pain-and-mobility-in-osteoarthritis-patients-treated-with-hylan-g-f-20/